Acquisitions and Divestiture (Tables)

12 Months Ended

Sep. 30, 2011

Unaudited Pro Forma Summary of Consolidated Information on Acquisition of Nexus

The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition of Nexus occurred on October 1, 2009 (in thousands):

	Year Ended
	September 30,
	2011		2010
Revenue	$	720,989	$	625,128
Net income attributable to Brooks Automation, Inc.		124,114		70,205

RTS Life Science Limited

Assets and Liabilities of Business Acquired Recorded at Fair Values as of Acquisition Date

The assets and liabilities of RTS were recorded at their fair values as of the acquisition date as follows (in thousands):

Accounts receivable	$	3,156
Inventory		1,668
Other current assets		1,008
Property, plant and equipment		860
Completed technology		1,524
Customer relationships		577
Trademarks and trade names		64
Goodwill		3,556
Accounts payable		(1,397	)
Deferred revenue		(5,232	)
Other current liabilities		(2,403	)
Total purchase price, net of cash acquired	$	3,381

Nexus Biosystems Inc.

Assets and Liabilities of Business Acquired Recorded at Fair Values as of Acquisition Date

The assets and liabilities of Nexus were recorded at their fair values as of the acquisition date as follows (in thousands):

Accounts receivable	$	5,708
Inventory		7,481
Other current assets		4,522
Property, plant and equipment		12,527
Completed technology		6,000
Customer relationships		31,000
Trademarks and trade names		100
Goodwill		33,033
Accounts payable and accrued expenses		(6,563	)
Deferred revenue		(3,692	)
Other current liabilities		(1,534	)
Deferred tax liabilities		(2,584	)
Other long-term liabilities		(1,070	)
Total purchase price, net of cash acquired	$	84,928